Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 1.64 is 84% below its estimated 5-year average of 10.42, near the low end of its estimated 5-year range (0.46–133.10).
As of 2026-10-06T13:30:58.602Z. 1.18% below its estimated 12-month average of 1.66.
Calculation as of: 2026-10-06T13:30:58.602Z.
Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 412370d08cb3fb7a3c2e4d636897a8ea9259835d42853a062d33098765049a4f
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
1.64
PS RATIO AVG TTM
1.66
PS RATIO AVG 3Y
1.45
PS RATIO AVG 5Y
10.42
PS RATIO AVG 10Y
189.32
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1.18%
CURRENT VS 3Y AVG
+12.98%
CURRENT VS 5Y AVG
-84.26%
CURRENT VS 10Y AVG
-99.13%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.97
median of 355 covered companies
CURRENT VS SECTOR MEDIAN
-58.69%
vs the sector median at left
Market Cap
$387.87M
PS Ratio
N/A
TTM Avg
4297.49
3Y Avg
4297.49
5Y Avg
4297.49
Market Cap
$369.60M
PS Ratio
6.24
TTM Avg
6.19
3Y Avg
8.23
5Y Avg
116.26
Market Cap
$348.59M
PS Ratio
N/A
TTM Avg
73.59
3Y Avg
73.59
5Y Avg
73.59
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $379.26M | 1.64 | 1.66 | 1.45 | 10.42 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $387.87M | N/A | 4297.49 | 4297.49 | 4297.49 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $369.60M | 6.24 | 6.19 | 8.23 | 116.26 |
| Opus Genetics, Inc. (IRD)vs › | $368.66M | 37.40 | 117.36 | 59.63 | 59.63 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $368.13M | 5.64 | 5.21 | 3.68 | 6.70 |
| Agenus Inc. (AGEN)vs › | $353.54M | 2.66 | 1.38 | 1.35 | 2.67 |
| Shoulder Innovations, Inc. (SI)vs › | $405.64M | 6.75 | 6.84 | 6.99 | 6.99 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | N/A | 73.59 | 73.59 | 73.59 |
| Embecta Corp. (EMBC)vs › | $348.55M | 0.34 | 0.45 | 0.65 | 0.90 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $347.88M | 8.23 | 11.34 | 10.16 | 11.34 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
Reported statement amounts were converted from CAD to USD using the stored FMP exchange-rate calculation.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $47,878,394 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q3 FY2026Period ended 2025-12-31 | $74,480,254 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-06 |
| Q4 FY2026Period ended 2026-03-31 | $51,219,455 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-15 |
| Q1 FY2027Period ended 2026-06-30 | $57,140,160 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $230,718,263 |
Current P/S: $379,263,955 market capitalization ÷ $230,718,263 TTM revenue = 1.64x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:30:00.000Z. Latest revenue period ended 2026-06-30.
At 1.64, P/S is at an extreme level, where the multiple carries little signal — higher than 15% of readings in its estimated 12-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 12-year low
0.46
median
198.95
estimated 12-year high
1732.48
P/S Ratio
1.64
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 1.62 |
| 2026-10-02 | 1.60 |
| 2026-10-01 | 1.61 |
| 2026-09-30 | 1.64 |
| 2026-09-29 | 1.69 |
| 2026-09-28 | 1.69 |
| 2026-09-25 | 1.72 |
| 2026-09-24 | 1.70 |
| 2026-09-23 | 1.71 |
| 2026-09-22 | 1.77 |
| 2026-09-21 | 1.69 |
| 2026-09-18 | 1.71 |
| 2026-09-17 | 1.72 |
| 2026-09-16 | 1.68 |
| 2026-09-15 | 1.68 |
| 2026-09-14 | 1.72 |
| 2026-09-11 | 1.70 |
| 2026-09-10 | 1.70 |
| 2026-09-09 | 1.76 |
| 2026-09-08 | 1.77 |
| 2026-09-04 | 1.78 |
| 2026-09-03 | 1.78 |
| 2026-09-02 | 1.77 |
| 2026-09-01 | 1.78 |
| 2026-08-31 | 1.82 |
| 2026-08-28 | 1.83 |
| 2026-08-27 | 1.85 |
| 2026-08-26 | 1.89 |
| 2026-08-25 | 1.96 |
| 2026-08-24 | 1.92 |
| 2026-08-21 | 1.92 |
| 2026-08-20 | 1.92 |
| 2026-08-19 | 1.90 |
| 2026-08-18 | 1.81 |
| 2026-08-17 | 1.83 |
| 2026-08-14 | 1.87 |
| 2026-08-13 | 1.85 |
| 2026-08-12 | 1.87 |
| 2026-08-11 | 1.83 |
| 2026-08-10 | 1.74 |
| 2026-08-07 | 1.65 |
| 2026-08-06 | 1.58 |
| 2026-08-05 | 1.58 |
| 2026-08-04 | 1.58 |
| 2026-08-03 | 1.63 |
| 2026-07-31 | 1.56 |
| 2026-07-30 | 1.56 |
| 2026-07-29 | 1.51 |
| 2026-07-28 | 1.52 |
| 2026-07-27 | 1.57 |
| 2026-07-24 | 1.51 |
| 2026-07-23 | 1.54 |
| 2026-07-22 | 1.55 |
| 2026-07-21 | 1.59 |
| 2026-07-20 | 1.59 |
| 2026-07-17 | 1.60 |
| 2026-07-16 | 1.58 |
| 2026-07-15 | 1.62 |
| 2026-07-14 | 1.63 |
| 2026-07-13 | 1.63 |
| 2026-07-10 | 1.65 |
| 2026-07-09 | 1.65 |
| 2026-07-08 | 1.64 |
| 2026-07-07 | 1.61 |
| 2026-07-06 | 1.63 |
| 2026-07-02 | 1.70 |
| 2026-07-01 | 1.61 |
| 2026-06-30 | 1.61 |
| 2026-06-29 | 1.69 |
| 2026-06-26 | 1.61 |
| 2026-06-25 | 1.55 |
| 2026-06-24 | 1.57 |
| 2026-06-23 | 1.61 |
| 2026-06-22 | 1.63 |
| 2026-06-18 | 1.64 |
| 2026-06-17 | 1.60 |
| 2026-06-16 | 1.63 |
| 2026-06-15 | 1.54 |
| 2026-06-12 | 1.57 |
| 2026-06-11 | 1.58 |
| 2026-06-10 | 1.58 |
| 2026-06-09 | 1.60 |
| 2026-06-08 | 1.60 |
| 2026-06-05 | 1.61 |
| 2026-06-04 | 1.63 |
| 2026-06-03 | 1.63 |
| 2026-06-02 | 1.66 |
| 2026-06-01 | 1.69 |
| 2026-05-29 | 1.71 |
| 2026-05-28 | 1.75 |
| 2026-05-27 | 1.68 |
| 2026-05-26 | 1.65 |
| 2026-05-22 | 1.63 |
| 2026-05-21 | 1.68 |
| 2026-05-20 | 1.61 |
| 2026-05-19 | 1.55 |
| 2026-05-18 | 1.54 |
| 2026-05-15 | 1.63 |
| 2026-05-14 | 1.68 |
| 2026-05-13 | 1.71 |
| 2026-05-12 | 1.71 |
| 2026-05-11 | 1.75 |
| 2026-05-08 | 1.74 |
| 2026-05-07 | 1.77 |
| 2026-05-06 | 1.80 |
| 2026-05-05 | 1.69 |
| 2026-05-04 | 1.72 |
| 2026-05-01 | 1.77 |
| 2026-04-30 | 1.74 |
| 2026-04-29 | 1.72 |
| 2026-04-28 | 1.80 |
| 2026-04-27 | 1.88 |
| 2026-04-24 | 1.86 |
| 2026-04-23 | 1.91 |
| 2026-04-22 | 2.16 |
| 2026-04-21 | 1.79 |
| 2026-04-20 | 1.88 |
| 2026-04-17 | 1.79 |
| 2026-04-16 | 1.80 |
| 2026-04-15 | 1.80 |
| 2026-04-14 | 1.71 |
| 2026-04-13 | 1.69 |
| 2026-04-10 | 1.65 |
| 2026-04-09 | 1.71 |
| 2026-04-08 | 1.63 |
| 2026-04-07 | 1.55 |
| 2026-04-06 | 1.60 |
| 2026-04-02 | 1.57 |
| 2026-04-01 | 1.53 |
| 2026-03-31 | 1.49 |
| 2026-03-30 | 1.34 |
| 2026-03-27 | 1.40 |
| 2026-03-26 | 1.44 |
| 2026-03-25 | 1.52 |
| 2026-03-24 | 1.50 |
| 2026-03-23 | 1.51 |
| 2026-03-20 | 1.48 |
| 2026-03-19 | 1.58 |
| 2026-03-18 | 1.60 |
| 2026-03-17 | 1.68 |
| 2026-03-16 | 1.60 |
| 2026-03-13 | 1.60 |
| 2026-03-12 | 1.63 |
| 2026-03-11 | 1.68 |
| 2026-03-10 | 1.66 |
| 2026-03-09 | 1.68 |
| 2026-03-06 | 1.68 |
| 2026-03-05 | 1.63 |
| 2026-03-04 | 1.69 |
| 2026-03-03 | 1.66 |
| 2026-03-02 | 1.68 |
| 2026-02-27 | 1.75 |
| 2026-02-26 | 1.79 |
| 2026-02-25 | 1.83 |
| 2026-02-24 | 1.83 |
| 2026-02-23 | 1.80 |
| 2026-02-20 | 1.86 |
| 2026-02-19 | 1.83 |
| 2026-02-18 | 1.80 |
| 2026-02-17 | 1.71 |
| 2026-02-13 | 1.69 |
| 2026-02-12 | 1.61 |
| 2026-02-11 | 1.68 |
| 2026-02-10 | 1.71 |
| 2026-02-09 | 1.71 |
| 2026-02-06 | 1.52 |
| 2026-02-05 | 1.49 |
| 2026-02-04 | 1.61 |
| 2026-02-03 | 1.62 |
| 2026-02-02 | 1.51 |
| 2026-01-30 | 1.51 |
| 2026-01-29 | 1.54 |
| 2026-01-28 | 1.58 |
| 2026-01-27 | 1.62 |
| 2026-01-26 | 1.65 |
| 2026-01-23 | 1.65 |
| 2026-01-22 | 1.62 |
| 2026-01-21 | 1.58 |
| 2026-01-20 | 1.59 |
| 2026-01-16 | 1.65 |
| 2026-01-15 | 1.69 |
| 2026-01-14 | 1.69 |
| 2026-01-13 | 1.73 |
| 2026-01-12 | 1.70 |
| 2026-01-09 | 1.70 |
| 2026-01-08 | 1.79 |
| 2026-01-07 | 1.65 |
| 2026-01-06 | 1.63 |
| 2026-01-05 | 1.65 |
| 2026-01-02 | 1.65 |
| 2025-12-31 | 1.58 |
| 2025-12-30 | 1.61 |
| 2025-12-29 | 1.67 |
| 2025-12-26 | 1.65 |
| 2025-12-24 | 1.81 |
| 2025-12-23 | 1.94 |
| 2025-12-22 | 1.83 |
| 2025-12-19 | 2.05 |
| 2025-12-18 | 2.34 |
| 2025-12-17 | 2.66 |
| 2025-12-16 | 2.53 |
| 2025-12-15 | 2.30 |
| 2025-12-12 | 2.41 |
| 2025-12-11 | 1.56 |
| 2025-12-10 | 1.59 |
| 2025-12-09 | 1.56 |
| 2025-12-08 | 1.51 |
| 2025-12-05 | 1.59 |
| 2025-12-04 | 1.67 |
| 2025-12-03 | 1.61 |
| 2025-12-02 | 1.54 |
| 2025-12-01 | 1.56 |
| 2025-11-28 | 1.62 |
| 2025-11-26 | 1.67 |
| 2025-11-25 | 1.65 |
| 2025-11-24 | 1.58 |
| 2025-11-21 | 1.54 |
| 2025-11-20 | 1.40 |
| 2025-11-19 | 1.45 |
| 2025-11-18 | 1.48 |
| 2025-11-17 | 1.45 |
| 2025-11-14 | 1.48 |
| 2025-11-13 | 1.52 |
| 2025-11-12 | 1.65 |
| 2025-11-11 | 1.66 |
| 2025-11-10 | 1.76 |
| 2025-11-07 | 1.12 |
| 2025-11-06 | 1.04 |
| 2025-11-05 | 1.09 |
| 2025-11-04 | 1.08 |
| 2025-11-03 | 1.15 |
| 2025-10-31 | 1.19 |
| 2025-10-30 | 1.17 |
| 2025-10-29 | 1.20 |
| 2025-10-28 | 1.24 |
| 2025-10-27 | 1.26 |
| 2025-10-24 | 1.29 |
| 2025-10-23 | 1.26 |
| 2025-10-22 | 1.26 |
| 2025-10-21 | 1.31 |
| 2025-10-20 | 1.33 |
| 2025-10-17 | 1.25 |
| 2025-10-16 | 1.29 |
| 2025-10-15 | 1.40 |
| 2025-10-14 | 1.30 |
| 2025-10-13 | 1.31 |
| 2025-10-10 | 1.31 |
| 2025-10-09 | 1.58 |
| 2025-10-08 | 1.47 |
| 2025-10-07 | 1.39 |
| 2025-10-06 | 1.33 |
| 2025-10-03 | 1.31 |
| 2025-10-02 | 1.30 |
| 2025-10-01 | 1.32 |
| 2025-09-30 | 1.40 |
| 2025-09-29 | 1.50 |
| 2025-09-26 | 1.28 |
| 2025-09-25 | 1.31 |
| 2025-09-24 | 1.36 |
| 2025-09-23 | 1.25 |
Showing the most recent 260 of 2,747 data points. The chart above shows the full history.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.